ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758035	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151452	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-21	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-21	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758036	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151453	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-29	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-29	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758037	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151454	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-3	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-3	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758038	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151455	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-6	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-6	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758039	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151456	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-12	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-12	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758040	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151457	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-15	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-15	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758041	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151458	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-20	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-20	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758042	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151459	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-24	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-24	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758043	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151460	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-13	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-13	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758044	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151461	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-4	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-4	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758045	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151462	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-7	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-7	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758046	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151463	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-8	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-8	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758047	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151464	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-11	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-11	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758048	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151465	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-16	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-16	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758049	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151466	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-2	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-2	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
GSE81380	28249907	HDAC inhibitor panobinostat engages host immune defenses to promote the tumoricidal effects of trastuzumab in HER2+ tumors	None	SRX1758050	GSE81380	AU565(pv) human breast tumor xenograft grown in the mammary fat pad of SCID mice	GSM2151467	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-22	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-22	Breast Cancer	None	Whole AU565(pv) tumor: human tumour cells, mouse stroma, epithelial cells and immune cells	None	None
